The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation
Benjamin Mizukawa(Cincinnati Children's Hospital Medical Center), Yi Zheng(University of Cincinnati Medical Center), Mark Wunderlich(Cincinnati Children's Hospital Medical Center), Cindy L. Hochstetler(Laboratoire d’immunologie intégrative du cancer), H. Leighton Grimes(Cincinnati Children's Hospital Medical Center), Xin Duan(University of Cincinnati), Emily Orr(Cincinnati Children's Hospital Medical Center), Eric O’Brien(Cincinnati Children's Hospital Medical Center), James C. Mulloy(Cincinnati Children's Hospital Medical Center), Wei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Daniel C. Moreira(St. Jude Children's Research Hospital)
Cited by 46
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
|Proceedings of the National Academy of Sciences|1997|526
Cyclin D Expression Is Controlled Post-transcriptionally via a Phosphatidylinositol 3-Kinase/Akt-dependent Pathway
|Journal of Biological Chemistry|1998|512